MedPath

The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases

Recruiting
Conditions
Thyroid Cancer
Registration Number
NCT06730529
Lead Sponsor
Ruijin Hospital
Brief Summary

This study aims to investigate the value of 68Ga-FAPI in the preoperative evaluation of thyroid cancer of different pathologic types.

Detailed Description

The investigators will number all participants, create a medical record file, and record their basic information (gender, age) as well as contact information and medical history information. All participants will undergo a 68Ga-FAPI PET/CT before surgery. The imaging response measurements will be compared with the histopathological results as gold standard.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Pathological and clinical diagnosis of thyroid cancer with lymph node metastases.
  2. Signed and dated informed consent form.
  3. Commitment to comply with research procedures and co-operation in the implementation of the full research process.
  4. Aged 16-80 years old.
Exclusion Criteria
  1. Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc.
  2. Intestinal perforation, complete intestinal obstruction.
  3. Pregnant women and women who may be pregnant, women who are breastfeeding.
  4. Non-compliant person.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical staging of thyroid cancer with lymph node metastasisWithin 1 week after enrollment

The value of 68Ga-FAPI PET/CT in the evaluation of thyroid cancer with lymph node metastases in clinical staging

Secondary Outcome Measures
NameTimeMethod
Standardized uptake value(SUV)Within 1 week after enrollment

SUV of 68Ga-FAPI uptake on PET/CT images for tumor lesions

Disease free survival3 years

Disease free survival

Trial Locations

Locations (1)

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath